EpiQuil co-founder and CEO Hélène Klein was awarded the CERI Women in Business Scholarship, recognising her entrepreneurial ambitions and leadership in life sciences. The scholarship supports her continued development as a founder and the advancement of EpiQuil's pharmaceutical innovation platform.
EpiQuil co-founder awarded CERI Women in Business Scholarship
Previous
Previous
EpiQuil receives ethics approval for preclinical pharmacokinetic study
Next
Next